European equities traded in the US as American depositary receipts were relatively flat Friday morning, edging 0.01% lower to 1,453.06 on the S&P Europe Select ADR Index, which ended the week up 1.4% and closed out the month nearly 4% higher.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and software firm SAP (SAP), which rose 2.4% and 1.7% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company Genfit (GNFT), which were up 1.2% and 0.9% respectively.
The decliners from continental Europe were led by pharmaceutical company Sanofi (SNY) and biotech firm BioNTech (BNTX), which fell 5.1% and 4.9% respectively. They were followed by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which lost 2.3% and 2.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and pharmaceutical company GSK (GSK), which increased 2.6% and 2.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and utilities company National Grid (NGG), which advanced 1.9% and 1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and NuCana (NCNA), which dropped 3.8% and 3% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Autolus Therapeutics (AUTL), which were down 2.9% and 2.3% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。